Market Closed -
TEL AVIV STOCK EXCHANGE
15:24:21 09/05/2024 BST
|
5-day change
|
1st Jan Change
|
1,097
ILa
|
+1.76%
|
|
-1.17%
|
-0.27%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,027
|
1,771
|
939.9
|
1,100
|
Enterprise Value (EV)
1 |
1,240
|
2,128
|
1,331
|
1,320
|
P/E ratio
|
17
x
|
18.5
x
|
9.68
x
|
14.9
x
|
Yield
|
1.95%
|
3.9%
|
4.47%
|
4.09%
|
Capitalization / Revenue
|
1.57
x
|
1.95
x
|
0.85
x
|
1.1
x
|
EV / Revenue
|
1.89
x
|
2.35
x
|
1.21
x
|
1.32
x
|
EV / EBITDA
|
12.2
x
|
13.6
x
|
8.67
x
|
9.54
x
|
EV / FCF
|
16,023,181
x
|
-24,991,266
x
|
170,166,597
x
|
5,821,204
x
|
FCF Yield
|
0%
|
-0%
|
0%
|
0%
|
Price to Book
|
2.54
x
|
4.09
x
|
1.52
x
|
1.93
x
|
Nbr of stocks (in thousands)
|
100,000
|
100,605
|
106,660
|
100,000
|
Reference price
2 |
10.27
|
17.60
|
8.812
|
11.00
|
Announcement Date
|
17/03/21
|
09/03/22
|
13/03/23
|
11/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
636.8
|
638.5
|
654.7
|
907.1
|
1,104
|
1,001
|
EBITDA
1 |
105.2
|
79.91
|
101.8
|
156.4
|
153.6
|
138.3
|
EBIT
1 |
87.11
|
65.99
|
85.65
|
139.5
|
131.1
|
114.2
|
Operating Margin
|
13.68%
|
10.34%
|
13.08%
|
15.37%
|
11.87%
|
11.41%
|
Earnings before Tax (EBT)
1 |
83.21
|
48.22
|
74.58
|
118.1
|
117.2
|
94.75
|
Net income
1 |
70.86
|
40.53
|
61.83
|
97.15
|
100.6
|
81.68
|
Net margin
|
11.13%
|
6.35%
|
9.44%
|
10.71%
|
9.11%
|
8.16%
|
EPS
2 |
0.6917
|
0.3951
|
0.6030
|
0.9500
|
0.9100
|
0.7400
|
Free Cash Flow
|
-
|
74.18
|
77.39
|
-85.16
|
7.822
|
226.7
|
FCF margin
|
-
|
11.62%
|
11.82%
|
-9.39%
|
0.71%
|
22.65%
|
FCF Conversion (EBITDA)
|
-
|
92.83%
|
76.04%
|
-
|
5.09%
|
163.87%
|
FCF Conversion (Net income)
|
-
|
183.01%
|
125.18%
|
-
|
7.77%
|
277.55%
|
Dividend per Share
|
-
|
-
|
0.2000
|
0.6867
|
0.3937
|
0.4495
|
Announcement Date
|
12/11/20
|
12/11/20
|
17/03/21
|
09/03/22
|
13/03/23
|
11/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
279
|
212
|
213
|
358
|
391
|
220
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.647
x
|
2.659
x
|
2.094
x
|
2.286
x
|
2.547
x
|
1.588
x
|
Free Cash Flow
|
-
|
74.2
|
77.4
|
-85.2
|
7.82
|
227
|
ROE (net income / shareholders' equity)
|
-
|
9.91%
|
15%
|
23.5%
|
20.1%
|
14%
|
ROA (Net income/ Total Assets)
|
-
|
5.24%
|
6.91%
|
10%
|
7.72%
|
6.5%
|
Assets
1 |
-
|
774.1
|
894.2
|
967.9
|
1,303
|
1,256
|
Book Value Per Share
2 |
3.930
|
4.230
|
4.040
|
4.300
|
5.810
|
5.700
|
Cash Flow per Share
2 |
0.1000
|
0.3400
|
0.2400
|
0.2200
|
0.2900
|
0.4600
|
Capex
1 |
19.3
|
26.3
|
11
|
21.2
|
32.5
|
34.9
|
Capex / Sales
|
3.03%
|
4.11%
|
1.69%
|
2.34%
|
2.94%
|
3.49%
|
Announcement Date
|
12/11/20
|
12/11/20
|
17/03/21
|
09/03/22
|
13/03/23
|
11/03/24
|
|
1st Jan change
|
Capi.
|
---|
| -0.27% | 310M | | +6.15% | 105B | | -4.19% | 65.16B | | +51.90% | 42.93B | | +17.59% | 39.48B | | +6.89% | 33.27B | | +12.40% | 19.92B | | +16.25% | 17.49B | | +20.35% | 15.43B | | +9.86% | 15.09B |
Other Commodity Chemicals
|